Direct-to-consumer (“DTC”) genetic testing companies are faced with more scrutiny than ever over their privacy practices, security practices, and ...

Nearly 7 million of 23andMe's customers were exposed in a recent data leak. Now they -- and potentially, you -- could be in line for a major payout.

ABC News’ speaks with law professor Anya Prince on how 23andMe’s recent layoffs and shuttering of its drug development arm ...

In the year since its hack, 23andMe has lost all of its value and most of its governing board — and somehow, things just keep ...

The genetic testing company 23andMe has agreed to a $30 million settlement in response to a class-action lawsuit claiming the company failed to adequately safeguard user data. The settlement comes ...

The personal data for nearly half of genetic testing customers -- 6.9 million people -- was exposed in the company's data breach. If you were one of these victims, you could be in line for a big ...

In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced Monday ...

No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

23andMe may well be the quintessential 2010s-era tech-adjacent ... In the meantime, it continues to pay out a $30 million ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...

American chief executive Robert Isom and JetBlue president Marty St. George on Tuesday each hinted that a new partnership was ...

By eliminating hundreds of jobs and stripping the therapeutic programs, 23andMe expects to save around $35 million. The company, once valued at $6 billion, experienced a severe drop in share prices ...